Triple
T7156883
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | NIH Director’s Pioneer Award |
E166834
|
entity |
| Predicate | fundedBy |
P67
|
FINISHED |
| Object |
NIH Office of the Director
The NIH Office of the Director is the central leadership and coordinating office of the National Institutes of Health, responsible for setting overall biomedical research priorities, policies, and strategic initiatives across the agency.
|
E645742
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NIH Office of the Director | Statement: [NIH Director’s Pioneer Award, fundedBy, NIH Office of the Director]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: NIH Office of the Director Context triple: [NIH Director’s Pioneer Award, fundedBy, NIH Office of the Director]
-
A.
National Institutes of Health
The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
-
B.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
-
C.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
D.
Office of Intramural Research
The Office of Intramural Research is a central NIH office that oversees and coordinates the biomedical research conducted within the NIH’s own laboratories and clinical centers.
-
E.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: NIH Office of the Director Triple: [NIH Director’s Pioneer Award, fundedBy, NIH Office of the Director]
Generated description
The NIH Office of the Director is the central leadership and coordinating office of the National Institutes of Health, responsible for setting overall biomedical research priorities, policies, and strategic initiatives across the agency.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: NIH Office of the Director Target entity description: The NIH Office of the Director is the central leadership and coordinating office of the National Institutes of Health, responsible for setting overall biomedical research priorities, policies, and strategic initiatives across the agency.
-
A.
National Institutes of Health
The National Institutes of Health is the United States’ primary federal biomedical research agency, supporting and conducting medical research to improve public health.
-
B.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
-
C.
Center for Scientific Review
The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
-
D.
Office of Intramural Research
The Office of Intramural Research is a central NIH office that oversees and coordinates the biomedical research conducted within the NIH’s own laboratories and clinical centers.
-
E.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c68887a5cc8190bec0ea96227164f7 |
completed | March 27, 2026, 1:39 p.m. |
| NER | Named-entity recognition | batch_69c6e80f14808190907ee84523630d85 |
completed | March 27, 2026, 8:26 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c7adb530388190b68fa05418d3e184 |
completed | March 28, 2026, 10:30 a.m. |
| NEDg | Description generation | batch_69c7ae830c74819091d6d65ac6fba32b |
completed | March 28, 2026, 10:33 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c7af1133b08190a32dccf82015c19e |
completed | March 28, 2026, 10:36 a.m. |
Created at: March 27, 2026, 2:47 p.m.